Telehealth company Amwell is expanding its partnership with Tyto Care, the all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams. Together, the two companies will introduce exclusive integrations and newly designed workflows and tools to enhance the ability for providers using the Amwell platform to examine and diagnose patients virtually. Additionally, Amwell will become a reseller of Tyto Care’s integrated devices.
Why does it matter?
By pairing the TytoHome handheld examination device — which enables on-demand examinations of the heart, lungs, abdomen, skin, throat, ears, heart rate, and body temperature — with Amwell’s telehealth platform, providers can guide patients through virtual health examinations and together gain real-time insight into a patient’s health data and status directly in the visit.
For patients and providers, this will augment the virtual care experience and more broadly enrich the capabilities and overall satisfaction associated with healthcare organizations’ virtual care applications. This enriched workflow will be available to thousands of Amwell hospitals, health systems, health plans and employer clients who collectively serve millions of patients.
On the record
“As COVID-19 wages on and more patients and providers adopt telehealth, it’s critical that we accelerate the depth of care that can be provided in the home – to keep patients and providers safe,” said Roy Schoenberg, President and Co-CEO of Amwell. “Our latest integration with Tyto Care will allow providers to clinically come closer than ever before to patients during telehealth encounters, allowing them to see, interact, examine and deliver care in ways that growingly resemble in-person care.”
“Our longstanding partnership with Amwell exemplifies our shared goal of providing deeply integrated telehealth solutions that put health in the hands of consumers, creating a more impactful and seamless healthcare experience for both patients and providers,” added Dedi Gilad, CEO and Co-Founder, Tyto Care. “The integration with TytoHome will enable Amwell to offer more holistic care for patients, especially for urgent and primary care needs, as well as help to enable better adherence to treatment plans. We look forward to continuing our work together as we realize the full potential of clinic-quality, at-home care in this new era of telehealth.”
While telehealth has been around for years in the United States, it was not until the coronavirus pandemic that it became regularly used. The growth of telehealth was fueled by the inability to see patients in person at the beginning of the pandemic and a move by the government to temporarily relax regulations.
Two of the leading telehealth companies went public – Teladoc in 2015, and Amwell earlier this year with a fresh funding from Google’s venture arm GV.